S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
CGC   15.33 (-3.22%)
GE   11.52 (+2.04%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
CGC   15.33 (-3.22%)
GE   11.52 (+2.04%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
CGC   15.33 (-3.22%)
GE   11.52 (+2.04%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
CGC   15.33 (-3.22%)
GE   11.52 (+2.04%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Pacific Biosciences of CaliforniaAccelerate DiagnosticsQuanterixFluidigmEyepoint Pharmaceuticals
SymbolNASDAQ:PACBNASDAQ:AXDXNASDAQ:QTRXNASDAQ:FLDMNASDAQ:EYPT
Price Information
Current Price$4.68$16.10$22.95$2.51$1.39
52 Week RangeHoldHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationHoldHoldBuyBuyBuy
Consensus Price Target$8.00$17.50$35.00$12.67$4.38
% Upside from Price Target70.94% upside8.70% upside52.51% upside404.65% upside214.75% upside
Trade Information
Market Cap$703.64 million$839.35 million$627.81 million$164.87 million$145.96 million
Beta1.682.721.252.31.79
Average Volume1,816,117189,207176,7321,254,839715,258
Sales & Book Value
Annual Revenue$78.63 million$5.67 million$37.63 million$112.96 million$2.96 million
Price / Sales9.10155.1817.081.5550.77
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.33 per share$0.19 per share$4.86 per share$2.34 per share$0.15 per share
Price / Book14.1884.744.721.079.27
Profitability
Net Income$-102,560,000.00$-88,330,000.00$-31,540,000.00$-59,010,000.00$-53,170,000.00
EPS($0.76)($1.62)($1.43)($0.80)($0.58)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-139.22%-1,116.69%-75.78%-57.10%-409.07%
Return on Equity (ROE)-136.85%-249.46%-54.74%-25.11%-250.32%
Return on Assets (ROA)-68.30%-51.36%-37.51%-12.90%-63.54%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.84%12.81%0.06%0.33%3.12%
Current Ratio1.52%21.93%7.61%2.89%4.54%
Quick Ratio1.22%18.89%4.91%2.48%4.29%
Ownership Information
Institutional Ownership Percentage71.16%55.11%61.79%97.10%57.37%
Insider Ownership Percentage11.60%47.60%30.80%2.20%41.29%
Miscellaneous
Employees40128717753555
Shares Outstanding152.96 million54.65 million28.01 million69.57 million108.12 million
Next Earnings Date2/10/2020 (Estimated)2/18/2020 (Estimated)3/16/2020 (Estimated)2/6/2020 (Estimated)3/12/2020 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
 Pacific Biosciences of CaliforniaAccelerate DiagnosticsQuanterixFluidigmEyepoint Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel